Gain Therapeutics
GANX
GANX
48 hedge funds and large institutions have $25.9M invested in Gain Therapeutics in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
26% more funds holding
Funds holding: 38 → 48 (+10)
8.87% more ownership
Funds ownership: 12.08% → 20.95% (+8.9%)
Holders
48
Holding in Top 10
–
Calls
$375K
Puts
$146K
Top Buyers
| 1 | +$3.97M | |
| 2 | +$1.61M | |
| 3 | +$667K | |
| 4 |
Jane Street
New York
|
+$453K |
| 5 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$427K |
Top Sellers
| 1 | -$997K | |
| 2 | -$290K | |
| 3 | -$159K | |
| 4 |
VF
Virtu Financial
New York
|
-$96K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$95.9K |
